AbbVie reportedly ending R&D deal with Alphabet-backed antiaging firm Calico

AbbVie (ABBV) stock is in focus as the company ends its decade-long R&D deal with Calico, an Alphabet (GOOG)-backed startup ...

Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q3 2025 Update

Davis Selected Advisers' Q3 2025 13F portfolio rose to $19.15B with 107 holdings, top positions in COF, META, AMAT, BRK, and ...

Comstock Announces Booz Allen in Landmark Reston Station Lease

Booz Allen joins a dynamic roster of leading global and national companies already located at Reston Station. Its workforce will benefit from a modern, walkable neighborhood filled with cafés, ...

Biotech and Pharma

There are about $10.5 billion of biotech convertibles outstanding, roughly 3% of the $305 billion market, according to BofA Securities. As part of the deal with Indonesia, the U.S. will have access to ...

Street Notes

The exclusive media rights agreement begins in 2026 and is worth an average of $1.1 billion a year. The Stock Market Will Continue Climbing, Says Analyst. 2 Sectors to Watch, and 1 to Avoid. Despite ...